SK284112B6 - 5-Substituované 1,2,4-tiadiazolylové deriváty, spôsob ich výroby a farmaceutické kompozície - Google Patents
5-Substituované 1,2,4-tiadiazolylové deriváty, spôsob ich výroby a farmaceutické kompozície Download PDFInfo
- Publication number
- SK284112B6 SK284112B6 SK1759-99A SK175999A SK284112B6 SK 284112 B6 SK284112 B6 SK 284112B6 SK 175999 A SK175999 A SK 175999A SK 284112 B6 SK284112 B6 SK 284112B6
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- compounds
- compound
- substituted
- acid addition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/83—Thioacids; Thioesters; Thioamides; Thioimides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
- C07D241/28—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms in which said hetero-bound carbon atoms have double bonds to oxygen, sulfur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97201931 | 1997-06-24 | ||
| US5300397P | 1997-07-10 | 1997-07-10 | |
| PCT/EP1998/004022 WO1998058919A1 (en) | 1997-06-24 | 1998-06-22 | Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK175999A3 SK175999A3 (en) | 2000-12-11 |
| SK284112B6 true SK284112B6 (sk) | 2004-09-08 |
Family
ID=8228478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1759-99A SK284112B6 (sk) | 1997-06-24 | 1998-06-22 | 5-Substituované 1,2,4-tiadiazolylové deriváty, spôsob ich výroby a farmaceutické kompozície |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0993452B1 (de) |
| JP (1) | JP2002505680A (de) |
| CN (1) | CN1084740C (de) |
| AT (1) | ATE372328T1 (de) |
| AU (1) | AU731712B2 (de) |
| BR (1) | BR9810314A (de) |
| CA (1) | CA2294581C (de) |
| CZ (1) | CZ296266B6 (de) |
| DE (1) | DE69838385T2 (de) |
| EE (1) | EE04746B1 (de) |
| ES (1) | ES2293687T3 (de) |
| HU (1) | HU224812B1 (de) |
| ID (1) | ID24231A (de) |
| IL (2) | IL133653A (de) |
| MY (1) | MY118312A (de) |
| NZ (1) | NZ501694A (de) |
| PL (1) | PL193438B1 (de) |
| RU (1) | RU2199538C2 (de) |
| SK (1) | SK284112B6 (de) |
| TR (1) | TR199903082T2 (de) |
| WO (1) | WO1998058919A1 (de) |
| ZA (1) | ZA985465B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2007134259A (ru) * | 2005-02-16 | 2009-03-27 | Шеринг Корпорейшн (US) | Гетероциклические замещенные пиперазины, обладающие антагонистическим действием к cxcr3 |
| JP2008266295A (ja) * | 2007-01-29 | 2008-11-06 | Santen Pharmaceut Co Ltd | キナーセ゛阻害活性を有する新規チアシ゛アソ゛ール誘導体 |
| CN108774215A (zh) * | 2018-08-15 | 2018-11-09 | 翟学旭 | 含氮杂环类衍生物及其在视网膜新生血管疾病中的应用 |
| CN108864064A (zh) * | 2018-08-15 | 2018-11-23 | 翟学旭 | 含氮杂环类衍生物及其在视网膜新生血管疾病中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6339868A (ja) * | 1986-08-04 | 1988-02-20 | Otsuka Pharmaceut Factory Inc | ジ低級アルキルフエノ−ル誘導体 |
| DE69705819T2 (de) * | 1996-01-15 | 2002-04-11 | Janssen Pharmaceutica N.V., Beerse | Angiogenesis hemmende pyridazinamine |
-
1998
- 1998-06-22 SK SK1759-99A patent/SK284112B6/sk unknown
- 1998-06-22 ES ES98937560T patent/ES2293687T3/es not_active Expired - Lifetime
- 1998-06-22 BR BR9810314-8A patent/BR9810314A/pt not_active Application Discontinuation
- 1998-06-22 CN CN98806394A patent/CN1084740C/zh not_active Expired - Fee Related
- 1998-06-22 AU AU86309/98A patent/AU731712B2/en not_active Ceased
- 1998-06-22 EE EEP199900582A patent/EE04746B1/xx not_active IP Right Cessation
- 1998-06-22 IL IL13365398A patent/IL133653A/xx not_active IP Right Cessation
- 1998-06-22 TR TR1999/03082T patent/TR199903082T2/xx unknown
- 1998-06-22 MY MYPI98002817A patent/MY118312A/en unknown
- 1998-06-22 PL PL98337649A patent/PL193438B1/pl not_active IP Right Cessation
- 1998-06-22 CZ CZ0448999A patent/CZ296266B6/cs not_active IP Right Cessation
- 1998-06-22 WO PCT/EP1998/004022 patent/WO1998058919A1/en active IP Right Grant
- 1998-06-22 AT AT98937560T patent/ATE372328T1/de not_active IP Right Cessation
- 1998-06-22 JP JP50382099A patent/JP2002505680A/ja not_active Ceased
- 1998-06-22 DE DE69838385T patent/DE69838385T2/de not_active Expired - Fee Related
- 1998-06-22 ID IDW991665A patent/ID24231A/id unknown
- 1998-06-22 NZ NZ501694A patent/NZ501694A/xx unknown
- 1998-06-22 CA CA002294581A patent/CA2294581C/en not_active Expired - Fee Related
- 1998-06-22 RU RU2000101856/04A patent/RU2199538C2/ru not_active IP Right Cessation
- 1998-06-22 EP EP98937560A patent/EP0993452B1/de not_active Expired - Lifetime
- 1998-06-22 IL IL14983098A patent/IL149830A/en not_active IP Right Cessation
- 1998-06-22 HU HU0004357A patent/HU224812B1/hu not_active IP Right Cessation
- 1998-06-23 ZA ZA9805465A patent/ZA985465B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9810314A (pt) | 2000-09-05 |
| ATE372328T1 (de) | 2007-09-15 |
| ES2293687T3 (es) | 2008-03-16 |
| IL149830A0 (en) | 2002-11-10 |
| ID24231A (id) | 2000-07-13 |
| HUP0004357A2 (hu) | 2002-02-28 |
| HU224812B1 (en) | 2006-02-28 |
| CZ296266B6 (cs) | 2006-02-15 |
| ZA985465B (en) | 1999-12-23 |
| HUP0004357A3 (en) | 2002-03-28 |
| EP0993452B1 (de) | 2007-09-05 |
| CN1261358A (zh) | 2000-07-26 |
| WO1998058919A1 (en) | 1998-12-30 |
| IL133653A0 (en) | 2001-04-30 |
| EE9900582A (et) | 2000-08-15 |
| NZ501694A (en) | 2000-10-27 |
| CA2294581A1 (en) | 1998-12-30 |
| EP0993452A1 (de) | 2000-04-19 |
| AU8630998A (en) | 1999-01-04 |
| IL133653A (en) | 2003-01-12 |
| DE69838385D1 (de) | 2007-10-18 |
| TR199903082T2 (xx) | 2000-07-21 |
| DE69838385T2 (de) | 2008-05-29 |
| RU2199538C2 (ru) | 2003-02-27 |
| IL149830A (en) | 2005-12-18 |
| JP2002505680A (ja) | 2002-02-19 |
| CZ448999A3 (cs) | 2000-08-16 |
| CN1084740C (zh) | 2002-05-15 |
| AU731712B2 (en) | 2001-04-05 |
| SK175999A3 (en) | 2000-12-11 |
| PL337649A1 (en) | 2000-08-28 |
| MY118312A (en) | 2004-09-30 |
| EE04746B1 (et) | 2006-12-15 |
| CA2294581C (en) | 2007-04-03 |
| PL193438B1 (pl) | 2007-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2334518T3 (es) | Derivados de n-(piridin-2-il)-sulfonamida. | |
| JP2730612B2 (ja) | ８‐クロロ‐１１‐〔１‐〔（５‐メチル‐３‐ピリジル）メチル〕‐４‐ピペリジリデン〕‐６，１１‐ジヒドロ‐５Ｈ‐ベンゾ〔５，６〕シクロヘプタ〔１，２‐ｂ〕ピリジン | |
| JP4316794B2 (ja) | イソキノリン誘導体及び医薬 | |
| KR20010042001A (ko) | 아릴피페리딘 유도체 및 그의 용도 | |
| WO2003002540A1 (en) | Cyclic diamine compound having five-membered cyclic group | |
| RU2194049C2 (ru) | Производные тиадиазолил пиридазина, ингибирующие ангиогенез, способ их получения, фармацевтическая композиция и способ ее получения | |
| SK284112B6 (sk) | 5-Substituované 1,2,4-tiadiazolylové deriváty, spôsob ich výroby a farmaceutické kompozície | |
| US7208503B2 (en) | Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives | |
| EP0661273B1 (de) | Indan Derivate und Verfahren zu deren Herstellung | |
| US6833369B2 (en) | Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives | |
| KR100534621B1 (ko) | 혈관형성을 저해하는 5-치환된-1,2,4-티아디아졸릴 유도체 | |
| US6265407B1 (en) | Angiogenesis inhibiting thiadiazolyl pyridazine derivatives | |
| JP2757353B2 (ja) | インダン誘導体、その製法及びその合成中間体 | |
| JP2003342175A (ja) | 新規なベンゾアゼピン誘導体又はその塩を有効成分とするメニエール病治療剤 | |
| JPH04295471A (ja) | トロポロン誘導体およびこれを有効成分とする虚血性疾患の予防・治療剤 |